Progenics Pharmaceuticals, Inc. CEO Mark Baker To Present At Jefferies and Co. Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., June 2, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced today that Chief Executive Officer Mark Baker will present on Thursday, June 5th, at 10:00 AM EDT at the Jefferies Global Healthcare Conference in New York City.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC